MARKET

VCYT

VCYT

Veracyte
NASDAQ
44.68
-1.73
-3.73%
Pre Market: 44.06 -0.62 -1.39% 05:42 08/13 EDT
OPEN
46.55
PREV CLOSE
46.41
HIGH
46.76
LOW
44.28
VOLUME
12
TURNOVER
0
52 WEEK HIGH
60.91
52 WEEK LOW
26.61
MARKET CAP
3.59B
P/E (TTM)
31.85
1D
5D
1M
3M
1Y
5Y
1D
Veracyte: Diagnostics With Favorable Economics
Seeking Alpha · 2d ago
Weekly Report: what happened at VCYT last week (0803-0807)?
Weekly Report · 3d ago
Veracyte: Core Growth Funds Prosigna And TrueMRD
Seeking Alpha · 3d ago
Veracyte Price Target Cut to $54.00/Share From $66.00 by Piper Sandler
Dow Jones · 08/04 14:52
Veracyte Is Maintained at Overweight by Piper Sandler
Dow Jones · 08/04 14:52
Piper Sandler Maintains Overweight on Veracyte, Lowers Price Target to $54
Benzinga · 08/04 14:41
Stephens Keeps Their Buy Rating on Veracyte (VCYT)
TipRanks · 08/04 13:45
Piper Sandler Sticks to Its Buy Rating for Veracyte (VCYT)
TipRanks · 08/04 13:26
More
About VCYT
Veracyte, Inc. is a global diagnostics company. It enables clinicians with insights they need to guide and assure patients. The Company offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder). Its Percepta Nasal Swab test is being run in its Clinical Laboratory Improvement Amendments (CLIA) lab in support of clinical studies and its tests for kidney cancer and lymphoma are in development, the latter as a companion diagnostic. Its products consist of the Prosigna breast cancer assay, the nCounter Analysis System, related diagnostic kits, and services. In the United States, it offers laboratory developed tests (LDTs), through its CLIA laboratories in South San Francisco and San Diego, California, supported by its cytopathology know-how in Austin, Texas. The Company also offers whole-genome MRD platform that enable it in early cancer diagnosis and risk assessment.

Webull offers Veracyte Inc stock information, including NASDAQ: VCYT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCYT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCYT stock methods without spending real money on the virtual paper trading platform.